Ten subjects (6 female subjects and 4 male subjects), 15.7
3.0
years of age (range: 10 –19 years), who had T1DM for
1 year
participated in the study. All subjects had hemoglobin A1c levels
of
10% and had been treated with an insulin pump for
3
months (Table 1). They were outpatients at the Institute for Endo-
crinology and Diabetes, National Center of Childhood Diabetes,
Schneider Children’s Medical Center of Israel. The research pro-
tocol was approved by the Ethics Committee for Clinical Investi-
gation and by the Israeli Ministry of Health. Written informed
consent was signed by all participants and by the parents of those
18 years of age